Our top pick for
Berkeley Lights, Inc is a biotechnology business based in the US. Berkeley Lights shares (BLI) are listed on the NASDAQ and all prices are listed in US Dollars. Berkeley Lights employs 210 staff and has a trailing 12-month revenue of around USD$59.2 million.
|Latest market close||USD$90.17|
|52-week range||USD$50.26 - USD$98.93|
|50-day moving average||USD$80.8144|
|200-day moving average||USD$70.5043|
|Wall St. target price||USD$92.33|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||N/A|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2020-11-20)||7.63%|
|1 month (2020-10-27)||20.63%|
|3 months (2020-08-27)||41.60%|
|6 months (2020-05-23)||N/A|
|1 year (2019-11-23)||N/A|
|2 years (2018-11-23)||N/A|
|3 years (2017-11-23)||N/A|
|5 years (2015-11-23)||N/A|
|Revenue TTM||USD$59.2 million|
|Gross profit TTM||USD$43.5 million|
|Return on assets TTM||0%|
|Return on equity TTM||0%|
|Market capitalisation||USD$5.2 billion|
TTM: trailing 12 months
There are currently 916,643 Berkeley Lights shares held short by investors – that's known as Berkeley Lights's "short interest". This figure is 9.3% up from 838,352 last month.
There are a few different ways that this level of interest in shorting Berkeley Lights shares can be evaluated.
Berkeley Lights's "short interest ratio" (SIR) is the quantity of Berkeley Lights shares currently shorted divided by the average quantity of Berkeley Lights shares traded daily (recently around 115301.00628931). Berkeley Lights's SIR currently stands at 7.95. In other words for every 100,000 Berkeley Lights shares traded daily on the market, roughly 7950 shares are currently held short.
However Berkeley Lights's short interest can also be evaluated against the total number of Berkeley Lights shares, or, against the total number of tradable Berkeley Lights shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Berkeley Lights's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Berkeley Lights shares in existence, roughly 10 shares are currently held short) or 0.0309% of the tradable shares (for every 100,000 tradable Berkeley Lights shares, roughly 31 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Berkeley Lights.
Find out more about how you can short Berkeley Lights stock.
We're not expecting Berkeley Lights to pay a dividend over the next 12 months.
Berkeley Lights, Inc., a digital cell biology company that focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. It offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. The company was incorporated in 2011 and is based in Emeryville, California.
Everything we know about the NewRez IPO, plus information on how to buy in.
Everything we know about the Perella Weinberg IPO, plus information on how to buy in.
Everything we know about the Nanobiotix IPO, plus information on how to buy in.
Everything we know about the Diversey IPO, plus information on how to buy in.
Everything we know about the Certara IPO, plus information on how to buy in.
Everything we know about the Arrival IPO, plus information on how to buy in.
Everything we know about the iSpecimen IPO, plus information on how to buy in.
Everything we know about the IDEX Biometrics ASA IPO, plus information on how to buy in.
Steps to owning and managing MYSZ, with 24-hour and historical pricing before you buy.
Steps to owning and managing MG, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.